$Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization$

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization

Abstract Background Switching to systemic therapy after transarterial chemoembolization (TACE) refractoriness is more inclined to preserve liver function and decrease disease progression. Hence, we conducted a comparison between the advantages of sorafenib therapy and the continuation of TACE in pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Reham Ashour, Eman Rewisha, Mohamed AKL Rady, Sally Waheed Elkhadry, Heba Abdelhalim, Mohamed Atef
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	BMC Cancer
Subjects:	Hepatocellular carcinoma Sorafenib Transarterial chemoembolization Refractorness Intermediate-stage patients
Online Access:	https://doi.org/10.1186/s12885-024-13199-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multiple acute complications of transarterial chemoembolization of liver metastases
by: R. N. Abu Shamsia, et al.
Published: (2024-12-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI)
by: Hai-Dong Zhu, et al.
Published: (2024-12-01)

Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
by: Korsic Spela, et al.
Published: (2024-10-01)

Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01)

Defining a radiomics feature selection method for predicting response to transarterial chemoembolization in hepatocellular carcinoma patients
by: Helen Zhang, et al.
Published: (2024-03-01)

Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization
by: CHENG Chienshan, ZHANG Tao, WU Junwei, GAO Huifeng, CHEN Jingxian, MENG Zhiqiang
Published: (2024-07-01)

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
by: Zhang G, et al.
Published: (2025-01-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

A Lipiodol Pickering Emulsion Stabilized by Iron‐Doped Carbon Nanozymes for Liver Transarterial Chemoembolization
by: Xiancheng Xia, et al.
Published: (2025-02-01)

Effect of Noise Management in Interventional Radiology Suites on Patients Undergoing Transarterial Chemoembolization: A Retrospective Study
by: Yong Lu, et al.
Published: (2024-09-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
by: Dongdong Xia, et al.
Published: (2025-01-01)

Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma
by: Xiaokai Zhang, et al.
Published: (2024-12-01)

ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER
by: A. V. Kozlov, et al.
Published: (2018-02-01)

CLINICAL CASE OF BCLC STAGE B HEPATOCELLULAR CARCINOMA WITH A COMBINED TREATMENT
by: Zagorulko Aleksey Ivanovich, et al.
Published: (2024-12-01)

Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study
by: Yuzhu Wang, et al.
Published: (2024-12-01)

Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2024-12-01)

Gemcitabine-Loaded Microbeads for Transarterial Chemoembolization of Rabbit Renal Tumor Monitored by <sup>18</sup>F-FDG Positron Emission Tomography/X-Ray Computed Tomography Imaging
by: Xiaoli Zhang, et al.
Published: (2024-12-01)

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System
by: Dongdong Zhang, et al.
Published: (2024-12-01)

Targeted regulation of autophagy using sorafenib-loaded biomineralization nanoenzyme for enhanced photodynamic therapy of hepatoma
by: Tianming Lu, et al.
Published: (2024-12-01)

Bibliometric study on the utilization of sorafenib in hepatocellular carcinoma
by: Wenjun Meng, et al.
Published: (2024-12-01)

Clinical outcomes after emergency transarterial renal embolization: a retrospective study
by: Rémi Grange, et al.
Published: (2024-12-01)

Clinical Outcome of Superselective Transarterial Embolization for Acute Colonic Gastrointestinal Bleeding: A Retrospective Single-Center Experience
by: Rajendra Kumar Behera, et al.

The Transcription Factor Creb is Involved in Sorafenib-Inhibited Renal Cancer Cell Proliferation, Migration and Invasion
by: Huang Shuaishuai, et al.
Published: (2018-12-01)

Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
by: Yinghao Wang, et al.
Published: (2021-12-01)

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis
by: Yirui Zhai, et al.
Published: (2025-03-01)

Erratum: Transarterial embolization in neonatal Kasabach–Merritt syndrome
by: Frontiers Production Office
Published: (2024-11-01)

The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
by: Huang X, et al.
Published: (2025-01-01)

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
by: Wu L, et al.
Published: (2025-01-01)

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
by: Jin Hyoung Kim, et al.
Published: (2024-10-01)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
by: Pusen Wang, et al.
Published: (2020-10-01)

In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation
by: Aya Anis, et al.
Published: (2024-12-01)

Transpulmonary chemoembolization and microwave ablation for recurrent or advanced non-small cell Lung Cancer
by: Thomas J. Vogl, et al.
Published: (2024-10-01)